IFN-γ induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: Implications for AIDS-Kaposi's sarcoma pathogenesis

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 1165-1170

  Fiorelli, Valeria ^a   Barillari, Giovanni ^b   Toschi, Elena ^b   Sgadari, Cecilia ^b   Monini, Paolo ^b   Stürzl, Michael ^c   Ensoli, Barbara ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ANTIBODY RESPONSE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INFLAMMATORY CELL; KAPOSI SARCOMA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SPINDLE CELL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; GENE PRODUCTS, TAT; GROWTH SUBSTANCES; HIV-1; HUMANS; INTERFERON TYPE II; RECEPTORS, FIBRONECTIN; RECEPTORS, VIRUS; RECEPTORS, VITRONECTIN; SARCOMA, KAPOSI; UMBILICAL VEINS; UP-REGULATION;

EID: 0033555401     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Friedman-Kien, A. E. 1981. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J. Am. Acad. Dermatol. 5:468.
2. Haverkos, H. W., D. P. Drotman, and M. Morgan. 1985. Prevalence of Kaposi's sarcoma among patients with AIDS. N. Engl. J. Med. 312:1518.
3. Beral, V. 1991. Epidemiology of Kaposi's sarcoma. Cancer Surv. 10:5.
4. Ruszczak, Z., A. Mayer-Da Silva, and C. E. Orfanos. 1987. Kaposi's sarcoma in AIDS: multicentric angioneoplasia in early skin lesions. Am. J. Dermatopathol. 9:388.
5. Regezi, J. A., L. A. MacPhail, T. E. Daniels, Y. G. DeSouza, J. S. Greenspan, and D. Greenspan. 1993. Human immunodeficiency virus-associated oral Kaposi's sarcoma: a heterogeneous cell population dominated by spindle-shaped endothelial cells. Am. J. Pathol. 143:240.
6. Dorfman, R. F., and F. R. C. Path. 1984. The histogenesis of Kaposi's sarcoma. Lymphology 17:76.
7. McNutl, N. S., V. Fletcher, and M. A. Conant. 1983. Early lesions of Kaposi's sarcoma in homosexual men: an ultrastructural comparison with other vascular proliferations in skin. Am. J. Pathol. 111:62.
8. Sirianni, M. C., L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, F. Aiuti, and B. Ensoli. 1998. γ-Interferon production in peripheral blood mononuclear cells (PBMC) and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages. Blood 91:968.
9. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: an immune response to HHV-8 infection? Blood 91:956.
10. Zhang, Y. M., S. Bachmann, C. Hemmer, J. van Lunzen, A. von Stemm, P. Kern, M. Dietrich, R. Ziegler, R. Waldherr, and P. P. Nawroth. 1994. Vascular origin of Kaposi's sarcoma: expression of leukocyte adhesion molecule-1, thrombo-modulin, and tissue factor. Am. J. Pathol. 144:51.
11. MacPhail, L. A., N. P. Dekker, and J. A. Regezi. 1996. Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma. J. Cutaneous Pathol. 23:464.
12. Uccini, S., L. P. Ruco, F. Monardo, A. Stoppacciaro, E. Dejana, I, Lesnoni La Parola, D. Cerimele, and C. D. Baroni. 1994. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J. Pathol. 173:23.
13. Little, D., W. Said, R. J. Siegel, M. Fealy, and M. C. Fishbein. 1986. Endothelial cell markers in vascular neoplasm: an immunohistochemical study comparing factor VIII-related antigen, blood group specific antigens, 6-keto-PGFIα, and Ulex Europaeus I lectin. J. Pathol. 149:89.
14. Ensoli, B., and M. Stürzl. 1998. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 9:63.
15. Hober, D., A. Haque, P. Wattre, G. Beaucaire, Y. Mouton, and A. Capron. 1989. Production of tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) in patients with AIDS: enhanced level of TNF-α is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78:329.
16. Fuchs, D., A. Hausen, G. Reibnegger, E. R. Werner, G. Werner-Felmayer, M. P. Dierich, and H. Wachter. 1989. Interferon-γ concentrations are increased in sera from individuals infected with human immunodeficiency virus type I. J. Acquired Immune Defic. Syndr. 2:158.
17. Emilie, D., M. Peuchmaur, M. C. Maillot, M. C. Crevon, N. Brousse, J. F. Delfraissy, J. Dormont, and P. Galanaud. 1990. Production of interleukins in human immunodeficiency virus-1 replicating lymph nodes. J. Clin. Invest. 86: 148.
18. Honda, M., K. Kitamura, Y. Mizutani, M. Oishi, M. Arai, T. Okura, S. Igarahi, K. Yasukawa, T. Hirano, Y. Kishimoto, R. Mitsuyasu, J. C. Chermann, and T. Tokugana. 1990. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-1-induced disease. J. Immunol. 145: 4059.
19. Vyakarnam, A., P. Matear, A. Meager, G. Kelly, B. Stanley, I. Weller, and P. Beverley. 1991. Altered production of tumor necrosis factors α and β and interferon-γ by HIV-1 infected individuals. Clin. Exp. Immunol. 84:109.
20. Rizzardini, G., S. Piconi, S. Ruzzante, M. L. Fusi, M. Lukwiya, S. Declich, M. Tamburrini, M. L. Villa, M. Fabiani, F. Milazzo, and M. Clerici. 1996. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS 10:1535.
21. Fagiolo, U., A. Cossarizza, E. Scala, E. Fanales-Belasio, C. Ortolani, E. Cozzi, D. Monti, C. Franceschi, and R. Paganelli. 1993. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23:2375.
22. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865.
23. De Lellis, L., M. Fabris, E. Cassai, A. Corallini, G. Giraldo, C. Feo, and P. Monini. 1995. Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma. J. Infect. Dis. 172:1605.
24. Montesano, R., L. Orci, and P. Vassalli. 1985. Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins. J. Cell. Physiol. 122:424.
25. Fiorelli, V., R. Gendelman, F. Samaniego, P. D. Markham, and B. Ensoli. 1995. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma cells. J. Clin. Invest. 95:1723.
26. Samaniego, F., P. Markham, R. Gendelman, R. C. Gallo, and B. Ensoli. 1997. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J. Immunol. 158:1887.
27. Samaniego, F., P. D. Markham, R. C. Gallo, and B. Ensoli. 1995. Inflammatory cytokines induce AIDS-Kaposi's sarcoma derived spindle cells to produce and release basic libroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J. Immunol. 154:3582.
28. Ensoli, B., S. Nakamura, S. Z. Salahuddin, P. Biberfeld, L. Larsson, B. Beaver, F. Wong-Staal, and R. C. Gallo. 1989. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223.
29. Xerri, L., J. Houssoun, J. Planche, V. Guigou, J. J. Grab, P. Parc, D. Birnbaum, and O. De Lapeyriere. 1991. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am. J. Pathol. 138:9.
30. Faris, M., B. Ensoli, N. Kokot, and A. Nel. 1998. Inflammatory cytokines induce the expression of bFGF isoforms required for growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements of the bFGF promoter. AIDS 12:19.
31. Ensoli, B., P. Markham, V. Kao, G. Barillari, V. Fiorelli, R. Gendelman, M. Raffeld, G. Zon, and R. C. Gallo. 1994. Block of AIDS-KS cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotides targeting basic fibroblast growth factor. J. Clin. Invest. 94:1736.
32. Cornali, E., C. Zietz, R. Benelli, W. Weninger, L. Masiello, G. Breier, E. Tschachler, A. Albini, and M. Stürzl. 1996. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol. 149:1851.
33. Samaniego, F., P. D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalski, J. A. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli. 1996. Vascular endothelial growth factor and basic fibroblast growth factor are expressed in Kaposi's sarcoma and synergize to induce angiogenesis, vascular permeability and KS lesion development: induction by inflammatory cytokines. Am. J. Pathol. 152:1433.
34. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84.
35. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular HIV-1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277.
36. Chang, H. C., F. Samaniego, B. C. Nair, L. Buonaguro, and B. Ensoli. 1997. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11:1421.
37. Barillari, G., L. Buonaguro, V. Fiorelli, J. Hoffman, F. Michaels, R. C. Gallo, and B. Ensoli. 1992. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149:3727.
38. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The Tat protein of human immunodeficiency virus type I, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using inlegrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
39. Albini, A., G. Barillari, R. Benelli, R. C. Gallo, and B. Ensoli. 1995. Angiogenic properties of human immunodeficiency virus type I Tat protein. Proc. Natl. Acad. Sci. USA 92:4838.
40. Lafrenie, R. M., L. M. Wahl, J. S. Epslein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1 Tat protein promotes chemotaxis and invasive behavior by monocytes. J. Immunol. 157:974.
41. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. S. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and the HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674.
42. 3 integrin. J. Acq. Immun. Defic. Syndr. Hum. Retroviruses. 14:A33 (abstr.).
43. Rinaldo, C., P. Piazza, Y. Z. Wang, J. Amstrong, P. Gupta, M. Ho, S. Petteway, D. Reed, D. Lyter, and L. Kingsley. 1988. HIV-1-specific production of IFN-γ and modulation by recombinant IL-2 during early HIV-1 infection. J. Immunol. 140:3389.
44. Caruso, A., R. Gonzales, R. Stellini, A. Scalzini, L. Peroni, and A. Turano. 1990. Interferon-γ marks activated T lymphocytes in AIDS patients. AIDS Res. Hum. Retroviruses 6:899.
45. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151:5031.
46. + T cells. Science 242:427.
47. Kleiner, D. E., and G. W. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218:325.
48. Taraboletti, G., D. Roberts, L. A. Liotta, and R. Giavazzi. 1990. Platelet thrombospondin modulates endothelial cell adhesion, motility and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111:765.
49. Oxholm, A., P. Oxholm, H. Permin, and K. Bendtzen. 1989. Epidermal tumor necrosis factor a and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. APMIS 97:533.
50. Cai, J., P. S. Gill, P. Masood, P. Chandrasoma, B. Jung, R. E. Law, and S. F. Radka. 1984. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am. J. Pathol. 145:74.
51. Miles, S. A., A. R. Rezai, J. F. Salazar-Gonzalez, M. VanderMeyden, R. H. Stevens, D. M. Logan, R. T. Mitsuyasu, T. Taga, T. Hirano, T. Kishimoto, and O. Martinez-Maza. 1990. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA 87:4068.
52. Krakauer, T., and J. J. Oppenheim. 1993. IL-1 and tumor necrosis factor a each up-regulate both the expression of IFN-γ and enhance IFN-γ-induced HLA-DR expression on human monocytes and a human monocytic cell line. J. Immunol. 150:1205.
53. Kleiner, D. E., and W. G. Stetler-Stevenson. 1993. Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell Biol. 5:891.
54. Mortarini, R., A. Anichini, and G. Parmiani. 1991. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins. Int. J. Cancer 47:551.
55. Klein, S., F. G. Giancotti, M. Presta, S. M. Albeda, C. A. Buck, and D. B. Rifkin. 1983. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell 4:973.
56. + T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145:59.
57. 1, integrins during human melanoma cell invasion. Cancer Res. 53:3411.
58. Ganju, R. K., N. Munshi, B. C. Nair, Z. Y. Liu, P. Gill, and J. E. Groopman. 1998. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinase, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72:6131.
59. Salahuddin, S. Z., S. Nakamura, P. Biberfeld, M. H. Kaplan, P. D. Markham, L. Larsson, and R. C. Gallo. 1988. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 242:430.
60. Krigel, R. L., C. M. Odajnyk, L. J. Laubenstein, J. Ostreicher, J. Wernz, J. Vilcek, P. Rubinstein, and A. E. Friedman-Kien. 1985. Therapeutic trial of interferon-γ in patients with epidemic Kaposi's sarcoma. J. Biol. Response Modif. 4:358.
61. Krigel, R. L., K. A. Padavic-Shaller, A. R. Rudolph, B. J. Poiesz, and R. L. Comis. 1989. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and γ-interferon: results of a phase 2 study. J. Biol. Response Modif. 8:359.
62. Albrecht, H., H. J. Stellbrink, G. Gross, B. Berg, U. Helmchen, and H. Mensing. 1994. Treatment of atypical leishmaniasis with interferon γ resulting in progression of Kaposi's sarcoma in an AIDS patient. Clin. Invest. 72:1041.